Office for Nuclear Regulation

This website uses non-intrusive cookies to improve your user experience. You can visit our cookie privacy page for more information.

Bradwell Compliance Inspection and Joint Regulatory Update Meeting

Executive summary

Purpose of intervention

This report describes an inspection of Magnox Ltd's Bradwell licensed site, undertaken as part of a series of routine interventions set out in the Integrated Intervention Strategy document.

Interventions Carried Out by ONR

I carried out a planned inspection of the site arrangements for LC7 Incidents on site, attended a joint regulatory project update meeting and considered the scenario for the forthcoming level 1 emergency exercise.

Key Findings, Inspector's Opinions and Reasons for Judgements Made

Reporting and investigation of events has a high profile at Bradwell and is given a high degree of attention by the site management team. This is appropriate given the large number of personnel on the site and the diverse range of hazards present on a decommissioning site.

There is a healthy event reporting culture on site and personnel actively participate in the operational experience feedback process.

I identified some examples where there is a misalignment between the ONR guidance on reporting of events to ONR and the corresponding Magnox company management control procedure. This issue is being addressed as part of a wider Magnox issue on incident notification arrangements.

Overall the LC7 inspection found the site's event reporting system to be comprehensive and of a good standard.

Conclusion of Intervention

From the evidence gathered during this intervention, no new matters have been identified that are likely to have a significant impact on nuclear safety at this time. However where potential improvements are identified these are shared with the site management. These corrective actions are captured with the site's Action Tracking arrangements, in the actions recorded in this intervention report or in the ONR issues database as appropriate. Therefore, no additional regulatory action arising from this visit is considered necessary at time.